Portfolio Holdings Detail for ISIN IE000T9EOCL3
| Stock Name / Fund | iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) |
| Issuer | |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | EWSA(USD) Euronext Amsterdam |
Holdings detail for CYTK
| Stock Name | Cytokinetics Inc |
| Ticker | CYTK(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US23282W6057 |
| LEI | 549300BE5DY1HW7IHA64 |
Show aggregate CYTK holdings
News associated with CYTK
- Cytokinetics Upsizes Convertible Notes Offering To $650 Mln
- (RTTNews) - Cytokinetics Inc. (CYTK) announced the pricing of its offering of $650.0 million aggregate principal amount of 1.75% convertible senior notes due 2031 in a private placement. The aggregate principal amount of the offering was increased from the previously announced of - 2025-09-17 02:15:35
- Cytokinetics, Incorporated (NASDAQ:CYTK) Receives $75.38 Average Target Price from Brokerages
- Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received an average rating of “Moderate Buy” from the fifteen research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the company. The […] - 2025-09-12 02:48:52
- Barclays Raises Cytokinetics (NASDAQ:CYTK) Price Target to $71.00
- Cytokinetics (NASDAQ:CYTK – Get Free Report) had its price objective upped by investment analysts at Barclays from $53.00 to $71.00 in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 42.71% from the […] - 2025-09-05 05:11:01
- Cytokinetics (NASDAQ:CYTK) Earns Buy Rating from Needham & Company LLC
- Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. They presently have a $72.00 price objective on the biopharmaceutical company’s stock. Needham & Company LLC’s target price suggests a potential upside of 44.03% from the […] - 2025-09-04 04:34:50
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 14:33:33
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 13:44:52
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:52:53
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:27:04
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 10:14:11
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 08:10:07
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 06:59:07
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 05:15:06
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 04:43:16
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 03:40:04
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 01:21:35
- Stocks Tumble on Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 20:15:06
- Stocks Under Pressure from Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 17:45:25
- Tuesday's ETF Movers: XBI, REMX
- In trading on Tuesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Mineralys Therapeutics, up about 87% and shares of Cytokinetics, up about 40.7% on the day.
And under - 2025-09-02 15:05:25
- Stocks Under Pressure from Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 13:49:14
- Stocks Tumble on Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 13:32:33
- Stocks Tumble on Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 12:50:37
- Thursday's ETF with Unusual Volume: TCAL
- The T Rowe Price Capital Appreciation Premium Income ETF is seeing unusually high volume in afternoon trading Thursday, with over 157,000 shares traded versus three month average volume of about 54,000. Shares of TCAL were down about 0.3% on the day.
Components of that ETF wit - 2025-08-21 13:31:24
- Vanguard Group Inc. Sells 66,274 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)
- Vanguard Group Inc. decreased its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 0.6% in the 1st quarter, HoldingsChannel reports. The fund owned 11,849,547 shares of the biopharmaceutical company’s stock after selling 66,274 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Cytokinetics worth $476,233,000 as of its most recent filing with […] - 2025-08-15 05:04:48
- Wall Street Zen Upgrades Cytokinetics (NASDAQ:CYTK) to “Hold”
- Cytokinetics (NASDAQ:CYTK – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “strong sell” rating to a “hold” rating in a research note issued to investors on Sunday. CYTK has been the topic of a number of other research reports. HC Wainwright reaffirmed a “buy” rating and issued a […] - 2025-08-12 02:18:50
- XTX Topco Ltd Cuts Stock Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK)
- XTX Topco Ltd trimmed its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 23.8% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,357 shares of the biopharmaceutical company’s stock after selling 2,293 shares during the period. XTX Topco Ltd’s holdings in Cytokinetics were worth $296,000 at the end of the […] - 2025-08-11 05:44:57
- Citigroup Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $77.00
- Cytokinetics (NASDAQ:CYTK – Free Report) had its price target reduced by Citigroup from $80.00 to $77.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on CYTK. Bank of America reduced their target […] - 2025-08-11 05:06:52
- KLP Kapitalforvaltning AS Acquires 600 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)
- KLP Kapitalforvaltning AS raised its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 2.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,600 shares of the biopharmaceutical company’s stock after acquiring an additional 600 shares during the quarter. KLP Kapitalforvaltning AS’s […] - 2025-07-29 06:16:49
- Edgestream Partners L.P. Makes New $732,000 Investment in Cytokinetics, Incorporated (NASDAQ:CYTK)
- Edgestream Partners L.P. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 18,216 shares of the biopharmaceutical company’s stock, valued at approximately $732,000. Other hedge funds and other institutional investors have […] - 2025-07-20 05:25:05
- Principal Financial Group Inc. Purchases 358,778 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)
- Principal Financial Group Inc. grew its stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 132.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 629,911 shares of the biopharmaceutical company’s stock after buying an additional 358,778 […] - 2025-07-09 05:45:06
- Noteworthy Thursday Option Activity: CYTK, GOOG, HOFT
- Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cytokinetics Inc (Symbol: CYTK), where a total of 7,451 contracts have traded so far, representing approximately 745,100 underlying shares. That amounts to about 46.8% o - 2025-06-12 18:17:36
iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) CYTK holdings
| Date | Number of CYTK Shares Held | Base Market Value of CYTK Shares | Local Market Value of CYTK Shares | Change in CYTK Shares Held | Change in CYTK Base Value | Current Price per CYTK Share Held | Previous Price per CYTK Share Held |
|---|
| 2025-11-27 (Thursday) | 7,268 | USD 495,314 | USD 495,314 | 0 | USD 0 | USD 68.15 | USD 68.15 |
| 2025-11-26 (Wednesday) | 7,268 | USD 495,314 | USD 495,314 | 0 | USD 4,361 | USD 68.15 | USD 67.5499 |
| 2025-11-25 (Tuesday) | 7,268 | USD 490,953 | USD 490,953 | 0 | USD 2,471 | USD 67.5499 | USD 67.21 |
| 2025-11-24 (Monday) | 7,268 | USD 488,482 | USD 488,482 | 0 | USD 12,864 | USD 67.21 | USD 65.44 |
| 2025-11-21 (Friday) | 7,268 | USD 475,618 | USD 475,618 | 0 | USD 14,100 | USD 65.44 | USD 63.5 |
| 2025-11-20 (Thursday) | 7,268 | USD 461,518 | USD 461,518 | 0 | USD -9,376 | USD 63.5 | USD 64.79 |
| 2025-11-19 (Wednesday) | 7,268 | USD 470,894 | USD 470,894 | 0 | USD -9,957 | USD 64.79 | USD 66.16 |
| 2025-11-18 (Tuesday) | 7,268 | USD 480,851 | USD 480,851 | 0 | USD -5,742 | USD 66.16 | USD 66.9501 |
| 2025-11-17 (Monday) | 7,268 | USD 486,593 | USD 486,593 | 0 | USD 3,707 | USD 66.9501 | USD 66.44 |
| 2025-11-14 (Friday) | 7,268 | USD 482,886 | USD 482,886 | 0 | USD 6,687 | USD 66.44 | USD 65.52 |
| 2025-11-13 (Thursday) | 7,268 | USD 476,199 | USD 476,199 | 0 | USD -3,053 | USD 65.52 | USD 65.94 |
| 2025-11-12 (Wednesday) | 7,268 | USD 479,252 | USD 479,252 | 0 | USD -4,070 | USD 65.94 | USD 66.5 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of CYTK by for IE000T9EOCL3
Show aggregate share trades of CYTK| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-11 | BUY | 456 | 66.720 | 61.660 | 62.166 | USD 28,348 | 40.60 |
| 2025-09-25 | BUY | 2,854 | 47.830 | 48.540 | 48.469 | USD 138,331 | 36.54 |
| 2025-07-31 | BUY | 306 | 37.640 | 38.590 | 38.495 | USD 11,779 | 36.63 |
| 2025-06-17 | BUY | 306 | 32.540 | 33.670 | 33.557 | USD 10,268 | 37.19 |
| 2025-05-30 | BUY | 1,040 | 31.020 | 31.420 | 31.380 | USD 32,635 | 38.07 |
| 2025-05-14 | BUY | 852 | 30.000 | 31.010 | 30.909 | USD 26,334 | 39.90 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of CYTK
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 308,076 | 25 | 563,329 | 54.7% |
| 2025-09-18 | 1,069,113 | 106 | 1,595,078 | 67.0% |
| 2025-09-17 | 3,257,527 | 19 | 3,868,954 | 84.2% |
| 2025-09-16 | 337,514 | 24 | 526,715 | 64.1% |
| 2025-09-15 | 361,864 | 15 | 698,010 | 51.8% |
| 2025-09-12 | 404,350 | 3,127 | 706,412 | 57.2% |
| 2025-09-11 | 503,860 | 0 | 714,130 | 70.6% |
| 2025-09-10 | 443,614 | 1,910 | 710,327 | 62.5% |
| 2025-09-09 | 294,540 | 614 | 847,716 | 34.7% |
| 2025-09-08 | 589,206 | 13,887 | 1,007,088 | 58.5% |
| 2025-09-05 | 885,382 | 1,927 | 1,782,623 | 49.7% |
| 2025-09-04 | 838,778 | 8,704 | 1,263,344 | 66.4% |
| 2025-09-03 | 1,154,392 | 61,354 | 2,027,559 | 56.9% |
| 2025-09-02 | 2,270,010 | 82,642 | 6,835,934 | 33.2% |
| 2025-08-29 | 457,459 | 0 | 1,416,959 | 32.3% |
| 2025-08-28 | 293,481 | 0 | 1,121,979 | 26.2% |
| 2025-08-27 | 294,025 | 933 | 1,144,344 | 25.7% |
| 2025-08-26 | 204,565 | 264 | 457,202 | 44.7% |
| 2025-08-25 | 340,072 | 1,960 | 636,074 | 53.5% |
| 2025-08-22 | 211,949 | 1,732 | 666,047 | 31.8% |
| 2025-08-21 | 282,349 | 0 | 493,514 | 57.2% |
| 2025-08-20 | 302,752 | 825 | 587,240 | 51.6% |
| 2025-08-19 | 401,347 | 114,635 | 656,506 | 61.1% |
| 2025-08-18 | 434,457 | 4,794 | 628,352 | 69.1% |
| 2025-08-15 | 270,258 | 2,531 | 472,143 | 57.2% |
| 2025-08-14 | 460,425 | 1,315 | 964,814 | 47.7% |
| 2025-08-13 | 464,252 | 1,223 | 831,333 | 55.8% |
| 2025-08-12 | 337,041 | 0 | 635,065 | 53.1% |
| 2025-08-11 | 349,138 | 355 | 707,945 | 49.3% |
| 2025-08-08 | 422,074 | 0 | 839,360 | 50.3% |
| 2025-08-07 | 259,893 | 0 | 357,917 | 72.6% |
| 2025-08-06 | 322,536 | 13 | 446,138 | 72.3% |
| 2025-08-05 | 178,071 | 0 | 399,750 | 44.5% |
| 2025-08-04 | 259,761 | 0 | 739,774 | 35.1% |
| 2025-08-01 | 253,991 | 1,600 | 371,404 | 68.4% |
| 2025-07-31 | 617,536 | 1,749 | 988,337 | 62.5% |
| 2025-07-30 | 220,893 | 300 | 432,202 | 51.1% |
| 2025-07-29 | 168,627 | 79 | 306,190 | 55.1% |
| 2025-07-28 | 258,000 | 0 | 333,371 | 77.4% |
| 2025-07-25 | 369,818 | 400 | 466,979 | 79.2% |
| 2025-07-24 | 162,114 | 98 | 287,211 | 56.4% |
| 2025-07-23 | 193,502 | 100 | 335,822 | 57.6% |
| 2025-07-22 | 337,958 | 0 | 457,195 | 73.9% |
| 2025-07-21 | 331,275 | 0 | 419,710 | 78.9% |
| 2025-07-18 | 289,154 | 0 | 450,118 | 64.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.